
Advanced Head and Neck Cancer Treatment: New Trial Shows Promising Results
Key Takeaways New head & neck cancer trial shows strong early tumor response. Bispecific antibody injection may shrink or remove tumors. In 102 patients, 43 saw shrinkage and 15 had no detectable cancer. Median survival ~12.5 months (early results). Still experimental, needs phase 3 trials. Estimated read: ~3 min What














